Unique Transcriptome, Pathways, and Networks in the Human Endometrial Fibroblast Response to Progesterone in Endometriosis

Supplemental Data

Supplemental Tables S1-S7

Files in this Data Supplement:

  • Supplemental Table S6 - Gene expression microarray studies performed on decidualized human endometrial stromal fibroblasts (hESF).
  • Supplemental Table S1 - List of regulated genes (BH corrected p-value < 0.05) in comparison of hESFendo treated with E2P4 for 6 h (hESFendo EP6) versus hESFnon-endo treated with E2P4 for 6 hours (hESFnonendo EP6), expressed as fold change (FC).
  • Supplemental Table S2 - List of regulated genes (BH corrected p-value < 0.05) in comparison of hESFendo treated with E2P4 for 48 hours (hESFendo EP48) versus hESFnon-endo treated with E2P4 for 48 h (hESFnonendo EP48), expressed as fold change (FC).
  • Supplemental Table S3 - List of regulated genes (BH corrected p-value < 0.05) in comparison of hESFendo treated with E2P4 for 14 days (hESFendo EP14) versus hESFnon-endo treated with E2P4 for 14 days (hESFnonendo EP14), expressed as fold change (FC).
  • Supplemental Table S4 - Canonical pathways in hESFendo and hESFnonendo.
  • Supplemental Table S5 - Networks regulated in hESFendo and hESFnonendo.
  • Supplemental Table S7 - Genes in common between hESFnonendo P4-response (14 days, decidualized phenotype) and hESFnonendo cAMP-response (96 h, decidualized phenotype).